← FDA DRUG APPROVALS

FDA NDA · NDA011325

VESPRIN

Sponsor: APOTHECON

APPLICATION
NDA011325
TYPE
NDA
ORIGINAL APPROVAL
1958-01-06
LATEST ACTION
1958-01-06
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

VESPRINDiscontinued
TRIFLUPROMAZINE HYDROCHLORIDE 10MG/ML · INJECTABLE · INJECTION
VESPRINDiscontinued
TRIFLUPROMAZINE HYDROCHLORIDE 3MG/ML · INJECTABLE · INJECTION
VESPRINDiscontinued
TRIFLUPROMAZINE HYDROCHLORIDE 20MG/ML · INJECTABLE · INJECTION

Approval history

1958-01-06Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →